Parmax Pharma Ltd.
Search Company
  You can view the Income statement for the last 5 years.
ISIN No INE240T01014 52Wk High (Rs.) 55 BV (Rs.) -7.21 FV (Rs.) 10.00
Bookclosure 30/09/2024 52Wk Low (Rs.) 28 EPS (Rs.) 0.00 P/E (X) 0.00
Mkt Cap. (Rs. Cr.) 13.09 P/BV (X) -4.85 Div Yield (%) 0.00 Mkt Lot 1
 
(Rs. in Crs.)
ParticularsSep 25Mar 25Sep 24Mar 24Sep 23
Net Sales/Income from operations4.4711.1117.095.585.47
Total Income From Operations4.4711.1117.095.585.47
      
EXPENDITURE     
Consumption of Raw Materials3.537.9313.615.361.67
Increase/Decrease in Stocks0.000.34-0.34-1.481.50
Employees Cost1.291.421.571.341.57
Depreciation0.500.230.800.860.85
Other Expenses1.491.881.542.312.15
Total Expenses6.8111.8017.188.407.74
      
P/L Before Other Inc. , Int., Excpt. Items & Tax-2.34-0.69-0.09-2.81-2.27
Other Income0.01-0.090.120.030.02
P/L Before Interest, Excpt. Items & Tax-2.32-0.770.04-2.79-2.24
Interest0.520.340.240.320.30
P/L Before Exceptional Items & Tax-2.84-1.12-0.20-3.11-2.55
Exceptional Items0.00-1.070.000.000.00
P/L Before Tax-2.84-2.19-0.20-3.11-2.55
Tax0.00-0.300.000.090.00
P/L After Tax from Ordinary Activities-2.84-1.89-0.20-3.20-2.55
Net Profit/Loss For the Period-2.84-1.89-0.20-3.20-2.55
      
Equity Share Capital3.743.743.743.743.74
Reserves And Surplus0.000.000.00-4.350.00
EPS Before Extra Ordinary *     
Basic EPS (Rs.)-7.60-5.05-0.55-8.56-6.81
Diluted EPS (Rs.)-7.60(5.05)-0.55(8.56)-6.81
EPS After Extra Ordinary *     
Basic EPS (Rs.) -7.60-5.05-0.55-8.56-6.81
Diluted EPS (Rs.) -7.600.00-0.550.00-6.81
      
PBITOE Margin (%)-52.23-6.20-0.51-50.40-41.46
PBTE Margin (%)-63.55-10.06-1.19-55.65-46.58
PBT Margin (%)-63.55-19.71-1.19-55.65-46.58
PAT Margin (%)-63.55-17.00-1.19-57.35-46.58